Financial Performance - Net loss for Q2 2024 increased significantly to $50.5 million, compared to $6.5 million in Q2 2023, primarily due to a non-cash impairment charge of $44.5 million[1] - Product revenues for the three months ended June 2024 were $180,182, compared to $788,430 for the same period in 2023, representing a decrease of approximately 77%[10] - Total costs and expenses for the three months ended June 2024 were $49,700,069, significantly higher than $7,231,059 for the same period in 2023, indicating an increase of over 586%[10] - Net loss for the six months ended June 2024 was $61,672,489, compared to a net loss of $12,994,814 for the same period in 2023, reflecting an increase of approximately 373%[10] - Basic and diluted net loss per share for the three months ended June 2024 was $(13.08), compared to $(1.69) for the same period in 2023, indicating a substantial increase in loss per share[11] Cash and Assets - Cash, cash equivalents, and restricted cash decreased to $0.7 million as of June 30, 2024, down from $9.2 million as of December 31, 2023[1] - Total current assets as of June 30, 2024, were $36.7 million, compared to $11.6 million as of December 31, 2023[8] - Total assets decreased to $127.4 million as of June 30, 2024, from $187.6 million as of December 31, 2023[8] - Cash, cash equivalents, and restricted cash at the end of the period were $728,339, down from $43,842,280 at the end of the same period in 2023, indicating a decrease of approximately 98%[12] Liabilities and Deficits - Current liabilities increased to $18.7 million as of June 30, 2024, from $14.6 million as of December 31, 2023[8] - Accumulated deficit rose to $282.3 million as of June 30, 2024, compared to $220.6 million as of December 31, 2023[8] Research and Development - Research and Development efforts in PEI are advancing in breeding, fish health, nutrition, and gene editing initiatives[3] - Research and development expenses for the three months ended June 2024 were $64,502, compared to $178,394 for the same period in 2023, reflecting a decrease of approximately 64%[10] Financing and Investments - The company is exploring financing initiatives to maintain liquidity, including the sale of additional equipment assets from the Ohio farm[2] - Long-lived asset impairment for the six months ended June 2024 was $48,733,222, compared to no impairment recorded for the same period in 2023[12] - Total cash used in investing activities for the six months ended June 2024 was $(1,894,051), a significant decrease from $(46,590,261) for the same period in 2023, showing an improvement of approximately 96%[12] Orders and Sales - AquaBounty secured a large follow-up order for conventional Atlantic salmon eggs from a major customer[3] Interest and Expenses - Interest expense for the three months ended June 2024 was $(989,976), compared to $(65,789) for the same period in 2023, indicating an increase of approximately 1500%[10] - Net cash used in operating activities for the six months ended June 2024 was $(8,698,367), a decrease from $(12,246,286) for the same period in 2023, showing an improvement of approximately 29%[12]

Harvard, Massachusetts--(Newsfile Corp. - August 6, 2024) - AquaBounty Technologies, Inc. (NASDAQ: AQB) ("AquaBounty" or the "Company"), a land-based aquaculture company utilizing technology to enhance productivity and sustainability, today announced the Company's financial results for the second quarter and six months ended June 30, 2024.Second Quarter 2024 Highlights and Recent DevelopmentsNet loss in the second quarter of 2024 was up significantly at $50.5 million as compared to $6.5 million in the seco ...

David F. Melbourne Jr. Promoted to Chief Executive Officer of AquaBounty; Sylvia Wulf to Continue as Non-Executive Board ChairJune 07, 2024 8:00 AM EDT | Source: AquaBounty Technologies, Inc.Harvard, Massachusetts--(Newsfile Corp. - June 7, 2024) - The Board of Directors of AquaBounty Technologies, Inc. (NASDAQ: AQB) ("AquaBounty" or the "Company"), a land-based aquaculture company utilizing technology to enhance productivity and sustainability, today announced that David F. Melbourne Jr. has ...

AquaBounty Technologies, Inc. (AQB) came out with a quarterly loss of $1.53 per share versus the Zacks Consensus Estimate of a loss of $1.42. This compares to loss of $1.80 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -7.75%. A quarter ago, it was expected that this company would post a loss of $1.52 per share when it actually produced a loss of $2.19, delivering a surprise of -44.08%.Over the last four quarters, the compan ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________ Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | --- | --- | |----------------------------------------------------------------------------------------------------------------------------------|----------------------- ...

Exhibit 99.1 AquaBounty Technologies Announces First Quarter 2024 Financial Results HARVARD, Mass., May 15, 2024 -- AquaBounty Technologies, Inc. (NASDAQ: AQB) ("AquaBounty" or the "Company"), a land-based aquaculture company utilizing technology to enhance productivity and sustainability, today announced the Company's financial results for the first quarter ended March 31, 2024. First Quarter 2024 Highlights and Recent Developments | --- | --- | |------------------------------------------------------------ ...

Table of Contents | --- | --- | --- | --- | --- | |----------------------------------------------------|--------------------|-----------------------------------------------------------------|-------------------------------|-------| | | | | | | | | | Commission file number: 001-36426 _____________________________ | | | | AquaBounty | (Exact name of | Technologies, registrant as specified in its charter) | Inc. | | | Delaware (State or other jurisdiction of | | | 04-3156167 (I.R.S. Employer | | | incorporatio ...

Exhibit 99.1 AquaBounty Technologies Announces Fourth Quarter and Full Year 2023 Financial Results HARVARD, Mass., April 1, 2024 -- AquaBounty Technologies, Inc. (NASDAQ: AQB) ("AquaBounty" or the "Company"), a land-based aquaculture company utilizing technology to enhance productivity and sustainability, today announced the Company's financial results for the fourth quarter and full year ended December 31, 2023. Fourth Quarter and Full Year 2023 Highlights and Recent Developments · Generated $553 thousand ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________ Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | --- | --- | |--------------------------------------------------------------------------------------------------------------------------------------|--------------- ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________ Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | --- | --- | |--------------------------------------------------------------------------------------------------------------------------------------|-------------------- ...